Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Monahan

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Gene Therapy|October 27, 2006
Transgene expression levels and kinetics determine risk of humoral immune response modeled in factor IX knockout and missense mutant miceT-P Zhang, D-Y Jin, R M Wardrop, et al.
Gene Therapy|April 16, 1998
Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophiliaP E Monahan, R J Samulski, J Tazelaar, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 26, 2012
Consequences of intra-articular bleeding in haemophilia: science to clinical practice and beyondA L Forsyth, G-É Rivard, L A Valentino, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 27, 2017
Recombinant porcine factor VIII for high-risk surgery in paediatric congenital haemophilia A with high-titre inhibitorS E Croteau, Y L Abajas, A S Wolberg, et al.
Journal of Thrombosis and Haemostasis : JTH|September 19, 2015
Inhibitor recurrence after immune tolerance induction: a multicenter retrospective cohort studyA Antun, P E Monahan, M J Manco-Johnson, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Gene Therapy|October 27, 2006
Transgene expression levels and kinetics determine risk of humoral immune response modeled in factor IX knockout and missense mutant miceT-P Zhang, D-Y Jin, R M Wardrop, et al.
Gene Therapy|April 16, 1998
Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophiliaP E Monahan, R J Samulski, J Tazelaar, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 26, 2012
Consequences of intra-articular bleeding in haemophilia: science to clinical practice and beyondA L Forsyth, G-É Rivard, L A Valentino, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 27, 2017
Recombinant porcine factor VIII for high-risk surgery in paediatric congenital haemophilia A with high-titre inhibitorS E Croteau, Y L Abajas, A S Wolberg, et al.
Journal of Thrombosis and Haemostasis : JTH|September 19, 2015
Inhibitor recurrence after immune tolerance induction: a multicenter retrospective cohort studyA Antun, P E Monahan, M J Manco-Johnson, et al.
Pageof 3